Pharma Journalist -

Progenra, Inc. announced a new immune-oncology drug whose mechanism differs from available cancer immunotherapies Opdivo and Keytruda. The findings, published by Progenra with Dr. Wayne…
Read More...

Evotec AG and MaRS Innovation today announced the launch of Fibrocor Therapeutics LP, a Toronto-based company focused on developing first-in-class therapeutics targeting fibrotic…
Read More...

Brazilian healthcare regulator Anvisa on Monday said it had issued the country's first license for sale of a cannabis-based drug in the country after years of legal wrangling with…
Read More...

Benitec Biopharma Limited is pleased to announce that the European Commission, based on a favourable recommendation from the European Medicines Agency (EMA) Committee for Orphan…
Read More...

The U.S. Supreme Court on Friday agreed to hear a dispute over whether companies that make copycat versions of biologic drugs must wait six months after winning federal approval to…
Read More...

Sunovion Pharmaceuticals Inc. (Sunovion) announced that results of a pivotal Phase 2/3 study (SEP360-202) evaluating novel drug candidate dasotraline in children ages 6 to 12 years with…
Read More...

Shionogi & Co., Ltd. has announced that cefiderocol (S-649266), a novel siderophore cephalosporin in late-stage development, met the FDA pre-specified primary endpoint for…
Read More...

Harrington Discovery Institute at University Hospitals in Cleveland, Ohio and the Alzheimer's Drug Discovery Foundation (ADDF) have expanded their collaboration to accelerate…
Read More...

Kitov Pharmaceuticals Holdings Ltd., an innovative biopharmaceutical company, announced the expansion of its pipeline through the acquisition of a majority stake in TyrNovo Ltd., a…
Read More...

Pharma major Lupin said that it has launched in the US market its generic version of morphine sulfate ER tablets used for management of severe pain. The company said it has launched…
Read More...